GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hangzhou AGS Medtech Co Ltd (SHSE:688581) » Definitions » Gross-Profit-to-Asset %

Hangzhou AGS Medtech Co (SHSE:688581) Gross-Profit-to-Asset % : 18.74% (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Hangzhou AGS Medtech Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Hangzhou AGS Medtech Co's annualized Gross Profit for the quarter that ended in Jun. 2024 was ¥435.3 Mil. Hangzhou AGS Medtech Co's average Total Assets over the quarter that ended in Jun. 2024 was ¥2,323.4 Mil. Therefore, Hangzhou AGS Medtech Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2024 was 18.74%.


Hangzhou AGS Medtech Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Hangzhou AGS Medtech Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou AGS Medtech Co Gross-Profit-to-Asset % Chart

Hangzhou AGS Medtech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial 61.61 43.62 101.42 62.02 25.71

Hangzhou AGS Medtech Co Quarterly Data
Dec17 Dec18 Dec19 Jun20 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.21 17.79 21.19 13.75 18.74

Competitive Comparison of Hangzhou AGS Medtech Co's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Hangzhou AGS Medtech Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou AGS Medtech Co's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hangzhou AGS Medtech Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Hangzhou AGS Medtech Co's Gross-Profit-to-Asset % falls into.



Hangzhou AGS Medtech Co Gross-Profit-to-Asset % Calculation

Hangzhou AGS Medtech Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=360.541/( (473.131+2331.074)/ 2 )
=360.541/1402.1025
=25.71 %

Hangzhou AGS Medtech Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Jun. 2024 )/( (Total Assets (Q: Mar. 2024 )+Total Assets (Q: Jun. 2024 ))/ count )
=435.32/( (2329.419+2317.316)/ 2 )
=435.32/2323.3675
=18.74 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Jun. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Hangzhou AGS Medtech Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Hangzhou AGS Medtech Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou AGS Medtech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 6 Kangxin Road, Building 597, Building 5, Yuhang District, Zhejiang Province, Hangzhou, CHN, 311106
Hangzhou AGS Medtech Co Ltd is engaged in Research & Development, production, and sales of endoscopic minimally invasive diagnosis and treatment devices. The company upholds the core values of create, insist, share, and providing patients and clinicians with safer and more efficient minimally invasive endoscopic devices, helping patients reduce pain and medical costs.
Executives
Zhang Cheng Director

Hangzhou AGS Medtech Co Headlines

No Headlines